Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide
Clinical trial NCT03139851 · COMPLETED
Trial details
- NCT number
- NCT03139851
- Sponsor
- Centre Leon Berard
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-27
- Primary completion
- 2018-09-26
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.